Related Experiment Videos
Proline, ascorbic acid, or thioredoxin affect jaundice and mortality in Long Evans cinnamon rats
1Torii Nutrient-stasis Project, Research Development Corporation of Japan, Yokohama, Japan.
Pharmacology, Biochemistry, and Behavior
|November 1, 1995
Summary
Proline and ascorbic acid treatments significantly delay mortality in Long Evans Cinnamon rats, an animal model for Wilson's disease. Combined antioxidant and proline therapy shows promise for treating liver dysfunction.
Area of Science:
- Hepatology
- Animal Models of Disease
- Nutritional Biochemistry
Background:
- The Long Evans Cinnamon (LEC) rat is a valuable animal model for Wilson's disease, exhibiting spontaneous hepatitis due to copper accumulation.
- Wilson's disease is characterized by excessive copper deposition in the liver, leading to severe liver damage and often mortality.
Purpose of the Study:
- To investigate the therapeutic potential of proline and ascorbic acid in mitigating hepatitis and delaying mortality in LEC rats.
- To explore the combined effects of proline and ascorbic acid, as well as the role of thioredoxin, in managing liver dysfunction.
Main Methods:
- Oral administration of proline and ascorbic acid to LEC rats.
- Feeding a copper-deficient diet.
- Intraperitoneal infusion of thioredoxin.
- Monitoring for the onset of jaundice and mortality.
Main Results:
- Oral proline administration significantly delayed mortality in LEC rats.
- A copper-deficient diet markedly delayed jaundice and mortality; proline further enhanced these effects.
- Ascorbic acid administration also delayed jaundice and mortality.
- Combined proline and ascorbic acid treatment demonstrated additive benefits.
- Thioredoxin infusion inhibited jaundice incidence.
Conclusions:
- Proline and ascorbic acid show therapeutic potential for Wilson's disease and other hepatic dysfunctions.
- Combined antioxidant and proline therapy may offer a beneficial treatment strategy.
- These findings highlight the role of nutritional and antioxidant interventions in managing liver disease.